clinical trial · NCT00455858
Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea
Novo Nordisk A/S·phase4·completed·n = 87
DiabetesDiabetes Mellitus, Type 2insulin detemir
brief summary
This trial is conducted in Asia. This trial aims for evaluating the glycaemic control, measured as glycosylated haemoglobin (Hb1Ac), of once daily insulin detemir as an add-on to oral antidiabetic drug (OAD) in subjects with type 2 diabetes mellitus in Korea.
started
Nov 1, 2007
primary completion
Oct 1, 2008
completion
Oct 1, 2008
last updated
Feb 1, 2024
official title
A 20-week, Multi-centre, Open-labelled, Non-comparative Evaluation of the Safety and Efficacy of Insulin Detemir in Combination With Oral Anti-diabetic Drug(s), in Subjects With Type 2 Diabetes Mellitus Who Were Inadequately Controlled on Current Therapy in Korea
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol